Skip Navigation LinksHome > Collections > Myeloma Collection (2010-2011)

Myeloma Collection (2010-2011)

Creator:   Editor
Created:   8/7/2010
Contains:  18 items
Myeloma articles published in 2010

The Melanoma Rollercoaster Continues: Resistance with B-RAF Inhibitor PLX4032 Takes Unexpected Turn

Free Access
PDF
+ Favorites
Request Permissions

ASH ANNUAL MEETING: For Myeloma Transplantation, Tradeoffs Result in Similar Outcomes for Tandem Autologous vs Auto-allogeneic Procedures

Free Access
PDF
+ Favorites
Request Permissions

ASH ANNUAL MEETING: Myeloma Phase III CALGB 100104 Study: Lenalidomide Maintenance Doubles Time to Disease Progression

Free Access
PDF
+ Favorites
Request Permissions

Multiple Myeloma: How Many Drugs in a Multi-Drug Regimen?

Free Access
PDF
+ Favorites
Request Permissions

Myeloma: Not All CRs Are Alike

Free Access
PDF
+ Favorites
Request Permissions

Multiple Myeloma: Allogeneic Transplant Has Role in Salvage Therapy

Free Access
PDF
+ Favorites
Request Permissions

Nurses Urged to Take on Greater Role with Multiple Myeloma Patients

Free Access
PDF
+ Favorites
Request Permissions

Myeloma: Novel-Agent Treatment Catching Up to Transplant Regimens

Free Access
PDF
+ Favorites
Request Permissions

Myeloma: Building on Len-Dex for Relapsed/Refractory Disease

Free Access
PDF
+ Favorites
Request Permissions

Myeloma: Bone-Targeted Therapy Results in 5-Month Longer Survival: MRC IX Study Results from European Hematology Association Congress

Free Access
PDF
+ Favorites
Request Permissions

From ASCO Annual Meeting: Maintenance Therapy Helping to Reduce Relapse Rates in Multiple Myeloma, Follicular Lymphoma

Free Access
PDF
+ Favorites
Request Permissions

Myeloma: Pomalidomide Found Active in Heavily Pretreated Patients

Free Access
PDF
+ Favorites
Request Permissions

Myeloma: New Drug Roundup

Free Access
PDF
+ Favorites
Request Permissions

Myeloma: Modified VISTA Induction Regimen Found Safe for Elderly Patients

Free Access
PDF
+ Favorites
Request Permissions

Transplantation in Multiple Myeloma: Research Roundup

Free Access
PDF
+ Favorites
Request Permissions

Multiple Myeloma: Big Survival Gains from Novel Agents 'in the Real World'

Duration: 3:52
Oncology Times 

Evangelos Terpos, speaking at the European Hematology Association 2010 Congress in Barcelona, discusses his group's encouraging findings based on 10 years of experience with thalidomide, lenalidomide, and bortezomib.

Download (906 KB)
+ Favorites

Program 2, Sunday Dec. 6

Creator: Peter Goodwin
Duration: 19:00
Oncology Times 

George Canellos, What’s hot from the ASH Plenary Session.

Maria-Victoria Mateos of Salamanca University in Spain on melphalan as the better partner drug for bortezomib in multiple myeloma; Commentary Dr. Canellos and Jesus San-Miguel, also of Salamanca, and Richard Van Etten of Tufts University.

Steven Devine of Ohio State University on T-cell depletion to avoid GVHD in AML; commentary from Dr. Canellos and Armand Keating of the University of Toronto.

Download (3.91 MB)
+ Favorites

Program 4, Day 4, Monday Dec 8

Creator: Peter Goodwin
Duration: 22:07
Oncology Times 

Prof Giuseppe Saglio of the University of Turin and San Luigi Gonzaga Hospital in Italy on nilotinib as a new standard of care for chronic myeloid leukaemia. ASH President Nancy Berliner of Brigham & Women's Hospital adds her thoughts.

Jorge Cortes of M. D. Anderson Cancer Center on three different ASH papers by his group looking at alternatives to standard imatinib in CML. Jane Apperley of Hammersmith Hospital and Imperial College London, reflects on these, and discusses strategies for dealing with imatinib resistance.

OT Broadcast News Scientific Editor George Canellos of Dana-Farber Cancer Institute on what some were jokingly calling a re-run of World War II that took place in the Non-Hodgkin’s Lymphoma session: R-CHOP 14 vs R-CHOP 21 in elderly patients with diffuse large B-cell lymphoma.

Andrzej Jakubowiak of the University of Michigan discusses a 4-drug regimen to treat newly diagnosed multiple myeloma....Ruben Niesvizky of Weill Cornell Medical College in New York City on the novel proteasome inhibitor carfilzomib, used in combination with lenalidomide and dexamethasone to treat relapsed or refractory multiple myeloma. OT interviewers: Peter Goodwin and Sarah Maxwell.

Download (4.89 MB)
+ Favorites
Collection Alerts

Stay up-to-date! Be notified every time a new item is added. Receive an Email or subscribe to an RSS feed.